Eton Pharmaceuticals, Inc. (ETON)
NASDAQ: ETON · IEX Real-Time Price · USD
3.800
-0.010 (-0.26%)
At close: Mar 27, 2024, 4:00 PM
3.880
+0.080 (2.11%)
After-hours: Mar 27, 2024, 7:59 PM EDT

Eton Pharmaceuticals Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Year 202320222021202020192018
Net Income
-0.94-9.02-1.96-27.97-18.32-37.23
Depreciation & Amortization
0.91.770.460.650.450.06
Share-Based Compensation
3.144.223.382.581.891.85
Other Operating Activities
3.717.85-6.612.4-2.042.68
Operating Cash Flow
6.824.82-4.72-22.35-18.03-8.15
Operating Cash Flow Growth
41.36%-----
Capital Expenditures
0-0.040.69-0.05-1.1-0.24
Other Investing Activities
-0.78-2.75-3.25--0.75-
Investing Cash Flow
-0.78-2.79-2.56-0.05-1.85-0.24
Share Issuance / Repurchase
0.20.250.5429.150.4521.96
Debt Issued / Paid
-1.16-0.39-0.152.484.750
Financing Cash Flow
-0.96-0.130.3931.635.221.96
Net Cash Flow
5.081.9-6.899.23-14.6713.58
Free Cash Flow
6.824.78-4.03-22.4-19.12-8.38
Free Cash Flow Growth
42.48%-----
Free Cash Flow Margin
20.88%20.89%-17.27%-57425.64%-1993.95%-
Free Cash Flow Per Share
0.270.19-0.16-1.07-1.08-1.31
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).